Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeaStar Medical HoldingICU -5.13%32 Receivables Turnover is 2.38 as of Mar. 2026. GuruFocus rates ICU with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 841 Biotechnology companies, SeaStar Medical Holding ranks better than 67.3% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. SeaStar Medical Holding's Revenue for the
three
months ended in Mar. 2026 was $0.50 Mil. SeaStar Medical Holding's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.21 Mil.
Hence, SeaStar Medical Holding's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.38.
SeaStar Medical Holding (NAS:ICU) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
SeaStar Medical Holding Receivables Turnover Related Terms
SeaStar Medical Holding Receivables Turnover Historical Data
* Premium members only.
The historical data trend for SeaStar Medical Holding's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SeaStar Medical Holding Receivables Turnover Chart
ICU vs TRAW, CALC, INAB: Receivables Turnover Comparison
For the Biotechnology subindustry, SeaStar Medical Holding's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SeaStar Medical Holding Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where SeaStar Medical Holding's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SeaStar Medical Holding (ICU) has a Receivables Turnover of 2.38 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SeaStar Medical Holding and its competitors. According to the industry distribution chart, SeaStar Medical Holding ranks #275 out of 841 companies in the Biotechnology industry, placing it in the top 32.7%.
Is SeaStar Medical Holding's Receivables Turnover too high?
SeaStar Medical Holding's current Receivables Turnover is 2.38. The Biotechnology industry median Receivables Turnover is 5.29. SeaStar Medical Holding's value of 2.38 is 55% below this industry median. Based on the distribution chart, SeaStar Medical Holding ranks #275 out of 841 companies in the Biotechnology industry, which is above the industry midpoint. Overall, SeaStar Medical Holding has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does SeaStar Medical Holding's Receivables Turnover compare to TRAW and CALC?
According to the Biotechnology industry distribution chart, SeaStar Medical Holding ranks #275 out of 841 companies for Receivables Turnover. This puts SeaStar Medical Holding in the upper half of its industry. The industry median Receivables Turnover is 5.29. SeaStar Medical Holding's value of 2.38 is 55% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.29, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SeaStar Medical Holding's current Receivables Turnover of 2.38 is 55% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on SeaStar Medical Holding and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SeaStar Medical Holding's current Receivables Turnover is 2.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SeaStar Medical Holding stock overvalued right now?
SeaStar Medical Holding (ICU) has a current Receivables Turnover of 2.38. The current Receivables Turnover is 2.38 and 55% below the Biotechnology industry median of 5.29. SeaStar Medical Holding's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For SeaStar Medical Holding (ICU), the current Receivables Turnover is 2.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
32GF Score
Get the complete analysis for ICU
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICU has been successfully added to your 
